Success Metrics

Clinical Success Rate
50.0%

Based on 1 completed trials

Completion Rate
50%(1/2)
Active Trials
1(33%)
Results Posted
0%(0 trials)
Terminated
1(33%)

Phase Distribution

No phase data available

Trial Status & Enrollment

Completion Rate

50.0%

1 of 2 finished

Non-Completion Rate

50.0%

1 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Completed(1)
Terminated(1)

Detailed Status

Active, not recruiting1
Terminated1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
50.0%

Trials by Status

active_not_recruiting133%
terminated133%
completed133%

Recent Activity

1 active trials
Showing 3 of 3
active_not_recruiting

Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update

NCT06935071
completed

Duffy-null Associated Neutrphil Count (DANC) Pediatric Patients

NCT06547931
terminated

Palliative Radiation Oncology Chief's Clinic

NCT03995927

Clinical Trials (3)

Showing 3 of 3 trials
NCT06935071

Endoprosthetic Replacement for Pathological Fractures of the Hip: A 35-year Update

Active Not Recruiting
NCT06547931

Duffy-null Associated Neutrphil Count (DANC) Pediatric Patients

Completed
NCT03995927

Palliative Radiation Oncology Chief's Clinic

Terminated

All 3 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
3